Clinical Trial Update: A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH) [Phase 2]

View source ↗

Summary

A Phase 2 study of tirzepatide in nonalcoholic steatohepatitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• Tirzepatide (tirzepatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Nonalcoholic Steatohepatitis | Phase 2 | Status: COMPLETED | Results posted: 2025-01-24